Crux Multiple Core Biopsy Device

Focus: 

To create a prototype device to enhance quality, yield, and speed of gastrointestinal biopsy collection

Anticipated Impact: 

Improved diagnosis of gastrointestinal disorders

Abstract: 

There have been no substantive innovations in endoscopic biopsy devices in nearly 40 years. Notably, current gastrointestinal (GI) biopsy forceps are associated with issues such as damage to the collected specimens and sampling inefficiencies. Crux Medical Innovations seeks to develop the Multiple Core Biopsy device to enhance quality, yield, and speed of GI biopsy collection, with the goal of improving disease diagnosis. Target customers are hospitals and physicians in the GI endoscopy market. This grant will support prototype design, fabrication, and testing. Crux anticipates that having a functional prototype will help secure funding for further development.


Collaborating organizations:  Product Creation Studio, University of Washington
 

Gastrointestinal Disease Diagnosis

Grant Update

Principal Investigator:
Bob Clements
Grantee Organization:
Crux Medical Innovations
Grant Title:
Crux Multiple Core Biopsy Device
Grant Cohort and Year:
2012 Proof of Concept (04)
Grant Period:
01/28/2013 - 01/27/2015 (Completed)
Grant Amount:
$250,000
Crux Medical Innovations is continuing to finalize the assembly of the MCB Device first design while continuing to study the merits of a second design intended to have improved manufacturability. While both designs present challenges, they each present unique advantages. Research continues on the second design, awaiting our third bench test in order to prove out critical steps. It is possible that prototypes of both designs will be completed and biopsy results of both compared for efficacy.

Impact in Washington

Location of LSDF Grantee
Locations of Collaborations/Areas of Impact
Issaquah
Seattle

Legislative Districts:
5, 11, 34, 36, 37, 43, 46

Health Impacts

Gastrointestinal Disease Diagnosis